Parvovirus B19 and the pathogenesis of rheumatoid arthritis: A case for historical reasoning

Lancet

Volumn 354, Issue 9183, 1999, Pages 1026-1027

  Lewin Altschuler, Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ERYTHEMA INFECTIOSUM; HUMAN; IMMUNE RESPONSE; JUVENILE RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; PARVOVIRUS; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SHORT SURVEY; SYNOVITIS;

EID: 0345035252     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)12312-7     Document Type: Note

References (16)

1. de la Mare WK. Abrupt mid-twentieth-century decline in Antarctic sea-ice extent from whaling records. Nature 1997; 389: 57-61.
2. White DG, Woolf AD, Mortimer PP, Cohen BJ, Blake DR, Bacon PA. Human parvovirus arthropathy. Lancet 1985; i: 419-21.
3. Reid DM, Reid TMS, Brown T, Rennie JAN, Eastmond CJ. Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet 1985; i: 422-25.
4. Saal JG, Steidle M, Einsele H, et al. Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatol Int 1992; 12: 147-51.
5. Kerr JR, Cartron JP, Curran MD, et al. A study of the role of parvovirus B19 in rheumatoid arthritis. Br J Rheumatol 1995; 34: 809-13.
6. Söderlund M, von Essen R, Haapasaari J, Kiistala U, Kiviluoto O, Hedman K. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 1997; 349: 1063-65.
7. Kingsley G. Microbial DNA in the synovium - a role in aetiology or a mere bystander? Lancet 1997; 349: 1038-39.
8. Takahashi Y, Murai C, Shibata S, et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci USA 1998; 95: 8227-32.
9. Short CL. The antiquity of rheumatoid arthritis. Arthritis Rheum 1974; 17: 193-205.
10. Rothschild BM, Turner KR, DeLuca MA. Symmetrical erosive peripheral polyarthritis in the Late Archaic Period of Alabama. Science 1988; 241: 1498-501.
11. Rothschild BM, Woods RJ, Rothschild C, Sebes JI. Geographic distribution of rheumatoid arthritis in ancient North America: implications for pathogenesis. Semin Arthritis Rheum 1992; 22: 181-87.
12. Brown KE, Young NS. Parvovirus B19 in human disease. Annu Rev Med 1997; 48: 59-67.
13. Chobra T, Anderson LJ. Erythema infectiosum (fifth disease). Clin Dermatol 1989; 7: 65-74.
14. Willan R. Reports of the diseases in London. Particularly during the years 1796, '97, '98, '99 and 1800. London: H L Galabin, 1801.
15. Bansal GP, Hatfield JA, Dunn FE, et al. Candidate recombinant vaccine for human B19 parvovirus. J Infect Dis 1993; 167: 1034-44.
16. Anderson S, Momoeda M, Kawase M, Kajigaya S, Young NS. Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits. Virology 1995; 206: 626-32.